Zdrowie i gospodarka · 14/04/2022
FDA Releases Draft Guidance on Diversity Plans for Clinical Trials
The FDA is releasing a draft guidance to help pharmaceutical companies develop plans to enroll more participants from underrepresented racial and ethnic groups in clinical trials in the US.
Source: Federal Register — Food and Drug AdministrationOpen original release →